Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Frontiers in Microbiology|June 16, 2015
Targeting glioblastoma via intranasal administration of Ff bacteriophagesEyal Dor-On, Beka SolomonArchives of Toxicology|February 11, 2021
New approach for the rational selection of markers to identify botulinum toxinsOsnat Rosen, Liron Feldberg, Eyal Dor, et al.Analytical Biochemistry|April 29, 2017
Optimization of SNAP-25-derived peptide substrate for improved detection of botulinum A in the Endopep-MS assayOsnat Rosen, Liron Feldberg, Eyal Dor, et al.Science Signaling|June 1, 2017
T-plastin is essential for basement membrane assembly and epidermal morphogenesisEyal Dor-On, Shaul Raviv, Yonatan Cohen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2010
TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variantsSara Orgad, Hemi Dimant, Eyal Dor-On, et al.International Journal of Molecular Sciences|August 27, 2021
Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and EAlon Ben David, Ada Barnea, Eran Diamant, et al.Toxins|October 22, 2021
A Rabbit Model for the Evaluation of Drugs for Treating the Chronic Phase of BotulismAmram Torgeman, Eran Diamant, Eyal Dor, et al.Scientific Reports|November 3, 2017
Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and EOsnat Rosen, Liron Feldberg, Tamar Shamai Yamin, et al.Journal of Neuro-Oncology|May 2, 2023
Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell linesHila Fishman, Roni Monin, Eyal Dor-On, et al.Antimicrobial Agents and Chemotherapy|May 11, 2021
A Novel Running Wheel Mouse Model for Botulism and Its Use for the Evaluation of Postsymptom Antitoxin EfficacyArieh Schwartz, Alon Ben David, Mordechai Hotoveli, et al.Pageof 4